Código QR (código de barras bidimensional)

The efficacy and safety of adjuvant immunotherapy after neoadjuvant immunotherapy combined with chemotherapy in locally advanced resectable esophageal squamous cell carcinoma: a real−world study

BackgroundThe promising therapeutic outcomes of neoadjuvant immunotherapy with chemotherapy (NAIC) in the treatment of resectable locally advanced esophageal squamous cell carcinoma (LA-ESCC) have been confirmed by several clinical trials. However, the potential benefits of adjuvant therapy for LA-E...

ver descrição completa

Na minha lista:
Principais autores: Xue Wu, Fangjie Ding, Shunshun Bao, Yiming Mu, Jiandong Zhang, Shuming Zhang, Pingping Hu, Yan Zhang, Ning Liang, Guodong Deng, Yuying Hao, Xinquan Liang, Fengxue Li, Yang Shu, Jingxin Zhang, Lili Qiao, Yingying Zhang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2025-05-01
coleção:Frontiers in Immunology
Assuntos:
adjuvant therapy
neoadjuvant therapy
immunotherapy
chemotherapy
esophageal squamous cell carcinoma (ESCC)
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1555756/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados